1.The Role of Histone Acetylation in Mesenchymal Stem Cell Differentiation
Sujeong JANG ; Jinsu HWANG ; Han-Seong JEONG
Chonnam Medical Journal 2022;58(1):6-12
		                        		
		                        			
		                        			 The mechanism and action concerning epigenetic modifications, especially that of histone modifications, are not fully understood. However, it is clear that histone modifications play an essential role in several biological processes that are involved in cell proliferation and differentiation. In this article, we focused on how histone acetylation may result in differentiation into mesenchymal stem cells as well as histone acetylation function. Moreover, histone acetylation followed by the action of histone deacetylase inhibitors, which can result in the differentiation of stem cells into other types of cells such as adipocytes, chondrocytes, osteocytes, neurons, and other lineages, were also reviewed. 
		                        		
		                        		
		                        		
		                        	
2.Group 1 metabotropic glutamate receptor 5 is involved in synaptically-induced Ca2+ -spikes and cell death in cultured rat hippocampal neurons
Ji Seon YANG ; Sujeong JEON ; Hyun-Jong JANG ; Shin Hee YOON
The Korean Journal of Physiology and Pharmacology 2022;26(6):531-540
		                        		
		                        			
		                        			 Group 1 metabotropic glutamate receptors (mGluRs) can positively affect postsynaptic neuronal excitability and epileptogenesis. The objective of the present study was to determine whether group 1 mGluRs might be involved in synapticallyinduced intracellular free Ca2+ concentration ([Ca2+ ] i ) spikes and neuronal cell death induced by 0.1 mM Mg2+ and 10 µM glycine in cultured rat hippocampal neurons from embryonic day 17 fetal Sprague–Dawley rats using imaging methods for Ca2+and 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays for cell survival. Reduction of extracellular Mg2+ concentration ([Mg2+ ] o ) to 0.1 mM induced repetitive [Ca2+ ] i spikes within 30 sec at day 11.5. The mGluR5 antagonist 6-Methyl-2-(phenylethynyl) pyridine (MPEP) almost completely inhibited the [Ca2+ ] i spikes, but the mGluR1 antagonist LY367385 did not. The group 1 mGluRs agonist, 3,5-dihydroxyphenylglycine (DHPG), significantly increased the [Ca2+ ] i spikes. The phospholipase C inhibitor U73122 significantly inhibited the [Ca2+ ] i spikes in the absence or presence of DHPG. The IP3 receptor antagonist 2-aminoethoxydiphenyl borate or the ryanodine receptor antagonist 8-(diethylamino)octyl 3,4,5-trimethoxybenzoate also significantly inhibited the [Ca2+ ] i spikes in the absence or presence of DHPG. The TRPC channel inhibitors SKF96365 and flufenamic acid significantly inhibited the [Ca2+ ] i spikes in the absence or presence of DHPG. The mGluR5 antagonist MPEP significantly increased the neuronal cell survival, but mGluR1 antagonist LY367385 did not. These results suggest a possibility that mGluR5 is involved in synapticallyinduced [Ca2+ ] i spikes and neuronal cell death in cultured rat hippocampal neurons by releasing Ca2+ from IP3 and ryanodine-sensitive intracellular stores and activating TRPC channels. 
		                        		
		                        		
		                        		
		                        	
3.Real-World Efficacy and Safety of Everolimus with Low Dose Tacrolimus in Liver Transplantation Recipients
Seoyoun JANG ; Boram KIM ; Sujeong JEON ; Kyung Suk CHOI ; Eunsook LEE ; Ju-Yeun LEE ; Euni LEE ; Ho-Seong HAN ; Jai Young CHO
Korean Journal of Clinical Pharmacy 2021;31(1):44-52
		                        		
		                        			Background:
		                        			Post-transplant immunosuppression with calcineurin inhibitors (CNIs) is associated with kidney function impairment while mammalian target of rapamycin (mTOR) inhibitors, such as everolimus, can be used for its renal-sparing effects. In this study, we compared the efficacy and safety of everolimus with low dose tacrolimus (EVR+Low TAC) and conventional dose tacrolimus (TAC) in liver transplantation recipients. 
		                        		
		                        			Methods:
		                        			Medical records of recipients who received liver transplantation at Seoul National University Bundang Hospital from January 1st 2009 to December 31st 2018 were retrospectively reviewed. Cohort entry date was defined as the day everolimus was initiated and tacrolimus dosage was reduced. All patients were followed up for 1 year. Indicator of efficacy was the incidence of rejection and safety was evaluated by incidence of drug adverse events including renal function. 
		                        		
		                        			Results:
		                        			Among 118 patients, there were 40 patients (33.9%) in EVR+Low TAC group. Incidence of rejection, including both biopsy proven acute rejection and clinical rejection, was similar in two groups [7.5% (n=3) vs. 6.4% (n=5), p=1.000]. Renal dysfunction was less frequent in EVR+Low TAC [17.5% (n=7) vs. 35.9% (n=28), p=0.038]. However, incidence rates of dyslipidemia, oral ulcer were more frequent in EVR+Low TAC [45.0% (n=18) vs. 21.8% (n=17), p=0.009; 15.0% (n=6) vs. 1.3% (n=1), p=0.006]. 
		                        		
		                        			Conclusions
		                        			In terms of prevention of rejection, EVR+Low TAC was as effective as TAC and had renal-sparing effect but was associated with increased risk of dyslipidemia and oral ulcer. This study demonstrates that EVR+Low TAC could be an alternative to liver transplant recipients with nephrotoxicity after administration of conventional dose tacrolimus.
		                        		
		                        		
		                        		
		                        	
4.Real-World Efficacy and Safety of Everolimus with Low Dose Tacrolimus in Liver Transplantation Recipients
Seoyoun JANG ; Boram KIM ; Sujeong JEON ; Kyung Suk CHOI ; Eunsook LEE ; Ju-Yeun LEE ; Euni LEE ; Ho-Seong HAN ; Jai Young CHO
Korean Journal of Clinical Pharmacy 2021;31(1):44-52
		                        		
		                        			Background:
		                        			Post-transplant immunosuppression with calcineurin inhibitors (CNIs) is associated with kidney function impairment while mammalian target of rapamycin (mTOR) inhibitors, such as everolimus, can be used for its renal-sparing effects. In this study, we compared the efficacy and safety of everolimus with low dose tacrolimus (EVR+Low TAC) and conventional dose tacrolimus (TAC) in liver transplantation recipients. 
		                        		
		                        			Methods:
		                        			Medical records of recipients who received liver transplantation at Seoul National University Bundang Hospital from January 1st 2009 to December 31st 2018 were retrospectively reviewed. Cohort entry date was defined as the day everolimus was initiated and tacrolimus dosage was reduced. All patients were followed up for 1 year. Indicator of efficacy was the incidence of rejection and safety was evaluated by incidence of drug adverse events including renal function. 
		                        		
		                        			Results:
		                        			Among 118 patients, there were 40 patients (33.9%) in EVR+Low TAC group. Incidence of rejection, including both biopsy proven acute rejection and clinical rejection, was similar in two groups [7.5% (n=3) vs. 6.4% (n=5), p=1.000]. Renal dysfunction was less frequent in EVR+Low TAC [17.5% (n=7) vs. 35.9% (n=28), p=0.038]. However, incidence rates of dyslipidemia, oral ulcer were more frequent in EVR+Low TAC [45.0% (n=18) vs. 21.8% (n=17), p=0.009; 15.0% (n=6) vs. 1.3% (n=1), p=0.006]. 
		                        		
		                        			Conclusions
		                        			In terms of prevention of rejection, EVR+Low TAC was as effective as TAC and had renal-sparing effect but was associated with increased risk of dyslipidemia and oral ulcer. This study demonstrates that EVR+Low TAC could be an alternative to liver transplant recipients with nephrotoxicity after administration of conventional dose tacrolimus.
		                        		
		                        		
		                        		
		                        	
5.Antidiabetic Drug Metformin Protects Neuronal Cells against Quinolinic Acid-Induced Excitotoxicity by Decreasing Intracellular Calcium
Chonnam Medical Journal 2018;54(1):24-30
		                        		
		                        			
		                        			The antidiabetic drug metformin has been found to have beneficial effects in various neurological disorders; however, the molecular mechanisms underlying these effects remain unclear. Here we report that metformin protects neuronal cells from quinolinic acid (QUIN)-induced excitotoxicity. For this, we pretreated N18D3 neuronal cells with metformin prior to QUIN for 24 h. We found that pretreating the cells with metformin significantly improved cell survival rate in a concentration-dependent manner and reduced apoptotic cell death, as revealed by a MTT assay and DAPI staining, respectively. Calcium imaging using fluo-4 showed that metformin (100 µM) inhibited the intracellular calcium increase that was induced by QUIN. In addition, mRNA expression of pro-apoptotic genes, p21 and Bax, was decreased and of anti-apoptotic genes, Bcl-2 and Bcl-xl, was increased with metformin treatment compared to QUIN-induced cells. The immunoreactivity of phosphorylated ERK1/2 was elevated in cells treated with metformin, indicating the ERK1/2 signaling pathway in the neuroprotective effects of metformin in QUIN-induced cell death. Collectively, our data demonstrates that metformin exerts its neuroprotective effects by inhibiting intracellular calcium increases, allowing it to regulate ERK1/2 signaling and modulate cell survival and death genes.
		                        		
		                        		
		                        		
		                        			Apoptosis
		                        			;
		                        		
		                        			Calcium
		                        			;
		                        		
		                        			Cell Death
		                        			;
		                        		
		                        			Cell Survival
		                        			;
		                        		
		                        			Genes, bcl-2
		                        			;
		                        		
		                        			Metformin
		                        			;
		                        		
		                        			Nervous System Diseases
		                        			;
		                        		
		                        			Neurons
		                        			;
		                        		
		                        			Neuroprotection
		                        			;
		                        		
		                        			Neuroprotective Agents
		                        			;
		                        		
		                        			Quinolinic Acid
		                        			;
		                        		
		                        			RNA, Messenger
		                        			
		                        		
		                        	
6.Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey.
Sang Heon KIM ; Ji Yong MOON ; Jae Hyun LEE ; Ga Young BAN ; Sujeong KIM ; Mi Ae KIM ; Joo Hee KIM ; Min Hye KIM ; Chan Sun PARK ; So Young PARK ; Hyouk Soo KWON ; Jae Woo KWON ; Jae Woo JUNG ; Hye Ryun KANG ; Jong Sook PARK ; Tae Bum KIM ; Heung Woo PARK ; You Sook CHO ; Kwang Ha YOO ; Yeon Mok OH ; Byung Jae LEE ; An Soo JANG ; Sang Heon CHO ; Hae Sim PARK ; Choon Sik PARK ; Ho Joo YOON
Allergy, Asthma & Immunology Research 2018;10(3):225-235
		                        		
		                        			
		                        			PURPOSE: Severe asthma and asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) are difficult to control and are often associated with poor clinical outcomes. However, much is not understood regarding the diagnosis and treatment of severe asthma and ACOS. To evaluate the current perceptions of severe asthma and COPD among asthma and COPD specialists, we designed an e-mail and internet-based questionnaire survey. METHODS: Subjects were selected based on clinical specialty from among the members of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Academy of Tuberculosis and Respiratory Diseases. Of 432 subjects who received an e-mail invitation to the survey, 95 subjects, including 58 allergists and 37 pulmonologists, responded and submitted their answers online. RESULTS: The specialists estimated that the percentage of severe cases among total asthma patients in their practice was 13.9%±11.0%. Asthma aggravation by stepping down treatment was the most common subtype, followed by frequent exacerbation, uncontrolled asthma despite higher treatment steps, and serious exacerbation. ACOS was estimated to account for 20.7% of asthma, 38.0% of severe asthma, and 30.1% of COPD cases. A history of smoking, persistently low forced expiratory volume in 1 second (FEV1), and low FEV1 variation were most frequently classified as the major criteria for the diagnosis of ACOS among asthma patients. Among COPD patients, the highly selected major criteria for ACOS were high FEV1 variation, positive bronchodilator response, a personal history of allergies and positive airway hyperresponsiveness. Allergists and pulmonologists showed different assessments and opinions on asthma phenotyping, percentage, and diagnostic criteria for ACOS. CONCLUSIONS: Specialists had diverse perceptions and clinical practices regarding severe asthma and ACOS patients. This heterogeneity must be considered in future studies and strategy development for severe asthma and ACOS.
		                        		
		                        		
		                        		
		                        			Allergy and Immunology
		                        			;
		                        		
		                        			Asthma*
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Electronic Mail
		                        			;
		                        		
		                        			Forced Expiratory Volume
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity
		                        			;
		                        		
		                        			Lung Diseases, Obstructive
		                        			;
		                        		
		                        			Population Characteristics
		                        			;
		                        		
		                        			Pulmonary Disease, Chronic Obstructive
		                        			;
		                        		
		                        			Smoke
		                        			;
		                        		
		                        			Smoking
		                        			;
		                        		
		                        			Specialization*
		                        			;
		                        		
		                        			Tuberculosis
		                        			
		                        		
		                        	
7.Neural-Induced Human Mesenchymal Stem Cells Promote Cochlear Cell Regeneration in Deaf Guinea Pigs.
Sujeong JANG ; Hyong Ho CHO ; Song Hee KIM ; Kyung Hwa LEE ; Jae Yeoul JUN ; Jong Seong PARK ; Han Seong JEONG ; Yong Beom CHO
Clinical and Experimental Otorhinolaryngology 2015;8(2):83-91
		                        		
		                        			
		                        			OBJECTIVES: In mammals, cochlear hair cell loss is irreversible and may result in a permanent sensorineural hearing loss. Secondary to this hair cell loss, a progressive loss of spiral ganglion neurons (SGNs) is presented. In this study, we have investigated the effects of neural-induced human mesenchymal stem cells (NI-hMSCs) from human bone marrow on sensory neuronal regeneration from neomycin treated deafened guinea pig cochleae. METHODS: HMSCs were isolated from the bone marrow which was obtained from the mastoid process during mastoidectomy for ear surgery. Following neural induction with basic fibroblast growth factor and forskolin, we studied the several neural marker and performed electrophysiological analysis. NI-hMSCs were transplanted into the neomycin treated deafened guinea pig cochlea. Engraftment of NI-hMSCs was evaluated immunohistologically at 8 weeks after transplantation. RESULTS: Following neural differentiation, hMSCs expressed high levels of neural markers, ionic channel markers, which are important in neural function, and tetrodotoxin-sensitive voltage-dependent sodium currents. After transplantation into the scala tympani of damaged cochlea, NI-hMSCs-injected animals exhibited a significant increase in the number of SGNs compared to Hanks balanced salt solution-injected animals. Transplanted NI-hMSCs were found within the perilymphatic space, the organ of Corti, along the cochlear nerve fibers, and in the spiral ganglion. Furthermore, the grafted NI-hMSCs migrated into the spiral ganglion where they expressed the neuron-specific marker, NeuN. CONCLUSION: The results show the potential of NI-hMSCs to give rise to replace the lost cochlear cells in hearing loss mammals.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Bone Marrow
		                        			;
		                        		
		                        			Cell Differentiation
		                        			;
		                        		
		                        			Cochlea
		                        			;
		                        		
		                        			Cochlear Nerve
		                        			;
		                        		
		                        			Colforsin
		                        			;
		                        		
		                        			Ear
		                        			;
		                        		
		                        			Fibroblast Growth Factor 2
		                        			;
		                        		
		                        			Guinea Pigs*
		                        			;
		                        		
		                        			Hair
		                        			;
		                        		
		                        			Hearing Loss
		                        			;
		                        		
		                        			Hearing Loss, Sensorineural
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Ion Channels
		                        			;
		                        		
		                        			Mammals
		                        			;
		                        		
		                        			Mastoid
		                        			;
		                        		
		                        			Mesenchymal Stromal Cells*
		                        			;
		                        		
		                        			Neomycin
		                        			;
		                        		
		                        			Neurons
		                        			;
		                        		
		                        			Organ of Corti
		                        			;
		                        		
		                        			Regeneration*
		                        			;
		                        		
		                        			Scala Tympani
		                        			;
		                        		
		                        			Sensory Receptor Cells
		                        			;
		                        		
		                        			Sodium
		                        			;
		                        		
		                        			Spiral Ganglion
		                        			;
		                        		
		                        			Transplantation
		                        			;
		                        		
		                        			Transplants
		                        			
		                        		
		                        	
8.Spontaneous Electrical Activity of Cultured Interstitial Cells of Cajal from Mouse Urinary Bladder.
Sun Ouck KIM ; Han Seong JEONG ; Sujeong JANG ; Mei Jin WU ; Jong Kyu PARK ; Han Yi JIAO ; Jae Yeoul JUN ; Jong Seong PARK
The Korean Journal of Physiology and Pharmacology 2013;17(6):531-536
		                        		
		                        			
		                        			Interstitial cells of Cajal (ICCs) from the urinary bladder regulate detrusor smooth muscle activities. We cultured ICCs from the urinary bladder of mice and performed patch clamp and intracellular Ca2+ ([Ca2+]i) imaging to investigate whether cultured ICCs can be a valuable tool for cellular functional studies. The cultured ICCs displayed two types of spontaneous electrical activities which are similar to those recorded in intact bladder tissues. Spontaneous electrical activities of cultured ICCs were nifedipine-sensitive. Carbachol and ATP, both excitatory neurotransmitters in the urinary bladder, depolarized the membrane and increased the frequency of spike potentials. Carbachol increased [Ca2+]i oscillations and basal Ca2+ levels, which were blocked by atropine. These results suggest that cultured ICCs from the urinary bladder retain rhythmic phenotypes similar to the spontaneous electrical activities recorded from the intact urinary bladder. Therefore, we suggest that cultured ICCs from the urinary bladder may be useful for cellular and molecular studies of ICCs.
		                        		
		                        		
		                        		
		                        			Action Potentials
		                        			;
		                        		
		                        			Adenosine Triphosphate
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Atropine
		                        			;
		                        		
		                        			Carbachol
		                        			;
		                        		
		                        			Interstitial Cells of Cajal*
		                        			;
		                        		
		                        			Membranes
		                        			;
		                        		
		                        			Mice*
		                        			;
		                        		
		                        			Muscle, Smooth
		                        			;
		                        		
		                        			Neurotransmitter Agents
		                        			;
		                        		
		                        			Phenotype
		                        			;
		                        		
		                        			Urinary Bladder*
		                        			
		                        		
		                        	
9.The Expression of Toll-Like Receptors (TLRs) in Cultured Human Skin Fibroblast is Modulated by Histamine
Sujeong JANG ; Jong Sung PARK ; Young Ho WON ; Sook Jung YUN ; Seong Jin KIM
Chonnam Medical Journal 2012;48(1):7-14
		                        		
		                        			
		                        			Fibroblasts are responsible for the synthesis and degradation of various connective tissue components and soluble mediators of extracellular matrix metabolism. Few studies have been conducted concerning the expression of toll-like receptors (TLRs) in fibroblasts until now. This study aimed first to determine the quantitative expression of TLRs 1 to 10 in human skin fibroblasts and secondarily to explore any influence of expression by histamine, which is a well-known factor engaged in dermal inflammation. It was found that all 10 TLRs were expressed in fibroblasts. Interestingly, the expression of TLRs 4, 5, and 10 was increased after 2 and 6 hours of histamine treatment during culture. However, the expression of TLRs 2, 3, 6, 7, 8, and 9 was decreased after 6 hours of histamine treatment. Among the TLRs with a decreasing expression pattern, TLRs 7 and 8 showed a persistent tendency to decrease. All of these changes in TLR expression with histamine treatment were antagonized by treatment with diphenhydramine, a well-known antihistamine. Thus, these results suggest a role of histamine in the early phase of the dermal inflammatory reaction mediated by TLRs.
		                        		
		                        		
		                        		
		                        			Connective Tissue
		                        			;
		                        		
		                        			Diphenhydramine
		                        			;
		                        		
		                        			Extracellular Matrix
		                        			;
		                        		
		                        			Fibroblasts
		                        			;
		                        		
		                        			Histamine
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			Skin
		                        			;
		                        		
		                        			Toll-Like Receptors
		                        			
		                        		
		                        	
10.Transplantation of Neural Differentiated Human Mesenchymal Stem Cells into the Cochlea of an Auditory-neuropathy Guinea Pig Model.
Yong Bum CHO ; Hyong Ho CHO ; Sujeong JANG ; Han Seong JEONG ; Jong Seong PARK
Journal of Korean Medical Science 2011;26(4):492-498
		                        		
		                        			
		                        			The aim of this study was to determine the effects of transplanted neural differentiated human mesenchymal stem cells (hMSCs) in a guinea pig model of auditory neuropathy. In this study, hMSCs were pretreated with a neural-induction protocol and transplanted into the scala tympani of the guinea pig cochlea 7 days after ouabain injury. A control model was made by injection of Hanks balanced salt solution alone into the scala tympani of the guinea pig cochlea 7 days after ouabain injury. We established the auditory neuropathy guinea pig model using 1 mM ouabain application to the round window niche. After application of ouabain to the round window niche, degeneration of most spiral ganglion neurons (SGNs) without the loss of hair cells within the organ of Corti and increasing the auditory brain responses (ABR) threshold were found. After transplantation of neural differentiated hMSCs, the number of SGNs was increased, and some of the SGNs expressed immunoreactivity with human nuclear antibody under confocal laser scanning microscopy. ABR results showed mild hearing recovery after transplantation. Based on an auditory neuropathy animal model, these findings suggest that it may be possible to replace degenerated SGNs by grafting stem cells into the scala tympani.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cardiotonic Agents/toxicity
		                        			;
		                        		
		                        			Cochlea/drug effects/pathology
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Guinea Pigs
		                        			;
		                        		
		                        			Hearing Loss, Central/chemically induced/pathology/*therapy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			*Mesenchymal Stem Cell Transplantation
		                        			;
		                        		
		                        			Mesenchymal Stem Cells/*cytology
		                        			;
		                        		
		                        			Neurogenesis
		                        			;
		                        		
		                        			Ouabain/toxicity
		                        			;
		                        		
		                        			Spiral Ganglion/pathology
		                        			;
		                        		
		                        			Transplantation, Heterologous
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail